YAP-TEAD interaction inhibitor (Inventiva)

N/A

Report date: 2025/03/19 11:41:47
NME

Base Information

Drug NameYAP-TEAD interaction inhibitor (Inventiva)
Drug Alias NameYAP-TEAD interaction modulator (Inventiva)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranscriptional enhancer factor inhibitorsTranscriptional coactivator YAP1 inhibitors
TargetsTranscriptional enhancer factorTranscriptional coactivator YAP1
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungLung NeoplasmsMesothelioma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInventiva SA
China Registration ClassN/A

Develop Information

Active CompaniesInventiva SA
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungLung NeoplasmsMesothelioma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A